New Mountain Vantage Advisers’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-152,579
Closed -$31.3M 48
2017
Q3
$31.3M Buy
152,579
+15,986
+12% +$3.72M 2.4% 21
2017
Q2
$33.2M Buy
136,593
+13,869
+11% +$3.26M 2.41% 20
2017
Q1
$29.3M Sell
122,724
-148,988
-55% -$34.7M 2.04% 27
2016
Q4
$57.1M Sell
271,712
-113,330
-29% -$23.5M 3.65% 5
2016
Q3
$88.7M Sell
385,042
-90,463
-19% -$22.1M 5.2% 3
2016
Q2
$110M Buy
475,505
+126,254
+36% +$29.1M 5.76% 2
2016
Q1
$93.6M Sell
349,251
-124,985
-26% -$35.8M 5.04% 2
2015
Q4
$148M Sell
474,236
-225,499
-32% -$67.1M 6.9% 2
2015
Q3
$190M Sell
699,735
-20,398
-3% -$6.27M 7.4% 1
2015
Q2
$219M Buy
720,133
+18,403
+3% +$5.49M 8.94% 1
2015
Q1
$209M Sell
701,730
-75,843
-10% -$21.6M 9.29% 1
2014
Q4
$200M Buy
777,573
+181,075
+30% +$45.3M 8.67% 1
2014
Q3
$144M Buy
596,498
+186,912
+46% +$41.8M 6.25% 2
2014
Q2
$91.4M Sell
409,586
-36,896
-8% -$7.64M 3.99% 7
2014
Q1
$91.9M Buy
446,482
+48,605
+12% +$9.63M 4.72% 4
2013
Q4
$66.8M Buy
397,877
+140,307
+54% +$21.9M 3.32% 10
2013
Q3
$37.1M Buy
257,570
+15,883
+7% +$2.12M 2.27% 22
2013
Q2
$30.5M Buy
+241,687
New +$27.4M 1.83% 28

Other funds holding AGN

New Mountain Vantage Advisers's AGN Position: Q4 2017 in Review

New Mountain Vantage Advisers sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 152,579 shares — an estimated $31.3M sold.

New Mountain Vantage Advisers first reported a position in AGN in Q2 2013 and held it in 18 quarters. The position peaked at $219M in Q2 2015. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • New Mountain Vantage Advisers reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • New Mountain Vantage Advisers sold 152,579 Allergan plc shares in Q4 2017, an estimated $31.3M.
  • New Mountain Vantage Advisers first reported a position in Allergan plc in Q2 2013 and held it in 18 quarters.
  • New Mountain Vantage Advisers's Allergan plc position peaked at $219M in Q2 2015.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on New Mountain Vantage Advisers's 13F filing for Q4 2017, filed 14 Feb 2018.